<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - OPIOIDS</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drugClass/">Drug classes</a></li>
      </ul>

      <h1>OPIOIDS</h1>

      <nav>
        <ul class="nav nav-list">

          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#treatmentCessation" data-toggle="tab">Treatment cessation</a></li>
          <li><a href="#drugsInClass" data-toggle="tab">Drugs in class</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">



      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Respiratory depression and withdrawal symptoms can occur in the neonate if opioid analgesics are used during delivery; also gastric stasis and inhalation pneumonia has been reported in the mother if opioid analgesics are used during labour.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Avoid use or reduce dose; may precipitate coma in patients with hepatic impairment.</p>
            </section>
      </section>


      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul>
            <li>Acute respiratory depression</li>
            <li>comatose patients</li>
            <li>head injury (opioid analgesics interfere with pupillary responses vital for neurological assessment)</li>
            <li>raised intracranial pressure (opioid analgesics interfere with pupillary responses vital for neurological assessment)</li>
            <li>risk of paralytic ileus</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

          <h3>General side effects</h3>
              <p>
                <strong>commonOrVeryCommon:</strong> Biliary spasm, bradycardia, confusion, constipation, dependence, difficulty with micturition, dizziness, drowsiness, dry mouth, dysphoria, euphoria, flushing, hallucinations, headache, hypotension (larger doses), miosis, mood changes, muscle rigidity (larger doses), nausea (particularly in initial stages), oedema, palpitation, postural hypotension, pruritus, rash, respiratory depression (larger doses), sexual dysfunction, sleep disturbances, sweating, tachycardia, ureteric spasm, urinary retention, urticaria, vertigo, visual disturbances, vomiting (particularly in initial stages),
              </p>
              <p>
                <strong>notKnown:</strong> Adrenal insufficiency (long-term use), hyperalgesia (long-term use), hypogonadism (long-term use),
              </p>
        
        
            <section class="advice">
                <h3>Hypogonadism and adrenal insufficiency</h3>
              <p>Long-term use of opioid analgesics can cause hypogonadism and adrenal insufficiency in both males and females. This is thought to be dose related and can lead to amenorrhoea, reduced libido, infertility, depression, and erectile dysfunction.</p>
            </section>
            <section class="advice">
                <h3>Hyperalgesia</h3>
              <p>Long-term use of opioid analgesics has also been associated with a state of abnormal pain sensitivity (hyperalgesia). Pain associated with hyperalgesia is usually distinct from pain associated with disease progression or breakthrough pain, and is often more diffuse and less defined. Treatment of hyperalgesia involves reducing the dose of opioid medication or switching therapy; cases of suspected hyperalgesia should be referred to a specialist pain team.</p>
            </section>
            <section class="advice">
                <h3>Respiratory depression</h3>
              <p>Respiratory depression is a major concern with opioid analgesics and it may be treated by artificial ventilation or be reversed by naloxone.</p>
            </section>
            <section class="advice">
                <h3>Dependence and withdrawal</h3>
              <p>Psychological dependence rarely occurs when opioids are used therapeutically (e.g. for pain relief) but tolerance can develop during long-term treatment.</p>
            </section>
        
            <section class="overdosageInformation">
              <p>Opioids (narcotic analgesics) cause coma, respiratory depression, and pinpoint pupils. For details on the management of poisoning, see Opioids, under <xref format="dita" href="#PHP78558" type="bookmark" namespace="/treatment-summaries/emergency-treatment-of-poisoning">Emergency treatment of poisoning</xref> and consider the specific antidote, <xref format="dita" href="#PHP202" type="drug" namespace="/drugs/naloxone-hydrochloride">naloxone hydrochloride</xref>.</p>
            </section>
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
            Adrenocortical insufficiency (reduced dose is recommended)
          </li>
          <li>
            asthma (avoid during an acute attack)
          </li>
          <li>
            convulsive disorders
          </li>
          <li>
            debilitated patients (reduced dose is recommended)
          </li>
          <li>
            diseases of the biliary tract
          </li>
          <li>
            elderly (reduced dose is recommended)
          </li>
          <li>
            hypotension
          </li>
          <li>
            hypothyroidism (reduced dose is recommended)
          </li>
          <li>
            impaired respiratory function (avoid in chronic obstructive pulmonary disease)
          </li>
          <li>
            inflammatory bowel disorders
          </li>
          <li>
            myasthenia gravis
          </li>
          <li>
            obstructive bowel disorders
          </li>
          <li>
            prostatic hypertrophy
          </li>
          <li>
            shock
          </li>
          <li>
            urethral stenosis
          </li>
        </ul>
        <ul>
          <li>
            <p>Repeated use of opioid analgesics is associated with the development of psychological and physical dependence; although this is rarely a problem with therapeutic use, caution is advised if prescribing for patients with a history of drug dependence.</p>
          </li>
          <li>
            <p>In the control of pain in terminal illness, the cautions listed should not necessarily be a deterrent to the use of opioid analgesics.</p>
          </li>
        </ul>
      </section>





      <section class="tab-pane" id="treatmentCessation">
        <h2>Advice regarding ceasing treatment</h2>

            <section class="treatmentCessation">
              <p>Avoid abrupt withdrawal after long-term treatment; they should be withdrawn gradually to avoid abstinence symptoms. </p>
            </section>
      </section>








      <section class="tab-pane" id="drugsInClass">
        <h2>Drugs in the class of OPIOIDS</h2>

          <ul>
            <li><a href="../drug/PHP2065.html">METHADONE HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP2610.html">CO-CODAMOL</a></li>
            <li><a href="../drug/PHP2623.html">CO-DYDRAMOL</a></li>
            <li><a href="../drug/PHP2680.html">BUPRENORPHINE</a></li>
            <li><a href="../drug/PHP2702.html">DIHYDROCODEINE TARTRATE</a></li>
            <li><a href="../drug/PHP2699.html">DIAMORPHINE HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP2727.html">HYDROMORPHONE HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP2731.html">MEPTAZINOL</a></li>
            <li><a href="../drug/PHP2766.html">OXYCODONE HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP2713.html">FENTANYL</a></li>
            <li><a href="../drug/PHP2777.html">PAPAVERETUM</a></li>
            <li><a href="../drug/PHP2783.html">PENTAZOCINE</a></li>
            <li><a href="../drug/PHP2785.html">PETHIDINE HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP2740.html">MORPHINE</a></li>
            <li><a href="../drug/PHP2789.html">TAPENTADOL</a></li>
            <li><a href="../drug/PHP2795.html">TRAMADOL HYDROCHLORIDE</a></li>
            <li><a href="../drug/PHP460.html">CODEINE PHOSPHATE</a></li>
            <li><a href="../drug/PHP464.html">CO-PHENOTROPE</a></li>
            <li><a href="../drug/PHP8594.html">ALFENTANIL</a></li>
            <li><a href="../drug/PHP8600.html">REMIFENTANIL</a></li>
            <li><a href="../drug/PHP88110.html">KAOLIN WITH MORPHINE</a></li>
            <li><a href="../drug/PHP98627.html">DIPIPANONE HYDROCHLORIDE WITH CYCLIZINE</a></li>
          </ul>
      </section>

    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
</body>
</html>
